Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-03-09Clinical Trial Update: Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy [Phase 3]
A Phase 3 clinical trial for patients with chronic hepatitis C genotype 1 or 3 who relapse after prior pegylated interferon/ribavirin therap…
-
CLINICAL_TRIALS research · 2007-03-07Clinical Trial Update: Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection [Phase 1]
This clinical trial update reports a Phase 1 study of XTL6865 for chronic hepatitis C; the current status of the trial is unknown.
-
CLINICAL_TRIALS withdrawal · 2007-01-12Clinical Trial Update: Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C [Phase 3]
Phase 3 trial evaluating pentoxifylline and tocopherol for liver fibrosis in chronic hepatitis C was terminated.
-
CLINICAL_TRIALS trial_result · 2007-01-05Clinical Trial Update: Study of Nitazoxanide in the Treatment of Chronic Hepatitis C [Phase 2]
A Phase 2 clinical trial evaluating nitazoxanide for chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-04Clinical Trial Update: Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C [Phase 2]
A Phase 2 trial comparing nitazoxanide plus peginterferon to peginterferon monotherapy for chronic hepatitis C has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-12-06Clinical Trial Update: Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha. [Phase 2]
Phase 2 clinical trial update evaluating whether omega-3 fatty acids can prevent depression in chronic hepatitis C patients treated with int…
-
CLINICAL_TRIALS trial_result · 2006-11-23Clinical Trial Update: Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus [Phase 2]
Phase 2 trial evaluating whether atorvastatin has antiviral activity against Hepatitis C virus has completed.
-
CLINICAL_TRIALS trial_result · 2006-11-14Clinical Trial Update: Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance [Phase 4]
Phase 4 clinical trial evaluating a combination of pegylated interferon, ribavirin, and metformin for chronic hepatitis C infection with ins…
-
CLINICAL_TRIALS trial_result · 2006-10-06Clinical Trial Update: Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation. [Phase 4]
A Phase 4 trial evaluating pegylated interferon in combination with ribavirin for hepatitis C after liver transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-29Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection [Phase 2]
A completed Phase 2 study evaluating the safety and efficacy of Celgosivir with Peginterferon alfa-2b, with or without Ribavirin, in patient…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV [Phase 2]
A Phase 2 clinical trial evaluating 4-Methylumbelliferone as a treatment for chronic hepatitis B and chronic hepatitis C is ongoing, with cu…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Timing and Duration of Acute Hepatitis C Treatment [Phase 4]
Phase 4 clinical trial update examining the timing and duration of treatment for acute Hepatitis C. The study is reported as completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Herbal Treatment of Hepatitis C in Methadone Maintained Patients [Phase 2]
A Phase 2 clinical trial evaluating an herbal treatment for hepatitis C in patients maintained on methadone has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: IdB 1016 Treatment for Hepatitis C Disease [Phase 1, Phase 2]
This update reports on the completed Phase 1/2 clinical trial of IdB 1016 for chronic hepatitis C.
-
CLINICAL_TRIALS research · 2006-08-18Clinical Trial Update: Evaluating Silymarin for Chronic Hepatitis C [Phase 2]
Phase 2 clinical trial update evaluating silymarin for chronic hepatitis C reports that the study is completed; trial results are not includ…
-
CLINICAL_TRIALS trial_result · 2006-08-15Clinical Trial Update: Pegintron Induction Therapy in HCV Non-Responders [Phase 3]
Phase 3 trial update reporting the completion of Pegintron induction therapy for hepatitis C in patients who did not respond to prior treatm…
-
CLINICAL_TRIALS trial_result · 2006-08-07Clinical Trial Update: Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C
This trial update reports on the long-term effects of pegylated interferon alfa-2a plus ribavirin in patients with chronic hepatitis C, incl…
-
CLINICAL_TRIALS withdrawal · 2006-07-27Clinical Trial Update: A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects [Phase 2]
A Phase 2 trial comparing Kaletra-based induction/maintenance therapy to a Sustiva-based regimen in previously untreated HIV-1/Hepatitis C c…
-
CLINICAL_TRIALS trial_result · 2006-07-14Clinical Trial Update: Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection [Phase 1, Phase 2]
A Phase 1/2 trial of KRN7000 for chronic hepatitis C has completed.
-
EMA withdrawal · 2006-06-28EMA Refused: Alpheon (recombinant human interferon alfa-2a) — BioPartners GmbH
The EMA refused approval for Alpheon (recombinant human interferon alfa-2a) from BioPartners GmbH for chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2006-06-13Clinical Trial Update: Continuing Treatment With Pegasys and Copegus [Phase 3]
An update on a Phase 3 trial evaluating Pegasys (peginterferon alfa-2a) and Copegus (ribavirin) for chronic hepatitis C, with the current st…
-
EMA withdrawal · 2006-06-01EMA Withdrawn: Infergen (interferon alfacon-1) — Astellas Pharma Europe B.V.
Infergen (interferon alfacon-1) has been withdrawn by Astellas Pharma Europe B.V. for chronic hepatitis C.